Kawada J, Sakai D, Kimura Y, Hirao M, et al. A Phase II Trial of Trastuzumab Combined With Irinotecan in Patients With Advanced HER2-positive Chemotherapy-refractory Gastric Cancer (OGSG1203 HERBIS-5): Final Results. Anticancer Res 2025;45:1077-1085.
PMID: 40037863